ÔÜíCovaxin, India's First Indigenous Vaccine Against COVID-19, Demonstrates 81% Efficacy, Claims Bharat Biotech

By Team Latestly

Indian COVID-19 vaccine maker Bharat Biotech on Wednesday released results of the Phase 3 clinical trial of Covaxin. The efficacy of Covaxin has been confirmed to be 81 percent in the Phase 3 trials.

Read Full Story